| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CHRS | Common Stock | Tax liability | $2,686 | -1,711 | -6.5% | $1.57 | 24,662 | 07 Jan 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction. |
| F2 | Includes 3,401 shares acquired on May 15, 2023 pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan. |